Murilo Lamim Bello

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Faculdade de Farmácia

Departamento:

Departamento de Fármacos e Medicamentos

ORCID:

https://orcid.org/0000-0003-0860-870X


Formação:

  • Universidade Federal Fluminense

    | Pós-Doutorado | 2014 - 2015

  • Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 2014 - 2014

  • Universidade Federal do Rio de Janeiro

    Tecnologia Industrial Farmacêutica - TIF | Especialização | 2010 - 2011

  • Universidade Federal do Rio de Janeiro

    Ciências Farmacêuticas | Doutorado | 2010 - 2014

  • Universidade Federal do Rio de Janeiro

    Ciências Farmacêuticas | Mestrado | 2009 - 2010

  • Universidade Federal Fluminense

    Ciência dos Medicamentos e Alimentos | Especialização | 2008 - 2009

  • Universidade do Oeste Paulista

    Farmácia | Graduação | 2004 - 2007
Laboratórios:
Nuvens de Palavras:
Artigos:

(97.44% artigos com DOI)

Titulo DOI Ano
Vanilla from Brazilian Atlantic Forest: In vitro and in silico toxicity assessment and high-resolution metabolomic analysis of Vanilla spp. ethanolic extracts 10.1016/j.foodchem.2024.139948 2024
GENE SET ENRICHMENT ANALYSIS INDICATES CONVERGENCE IN THE mTOR SIGNALLING PATHWAY BETWEEN SYNDROMIC AND NON-SYNDROMIC AUTISM 10.1016/j.neuri.2023.100119 2023
Virtual screening indicates potential inhibitors of the P2X7 receptor 10.1016/j.compbiomed.2023.107299 2023
In vitro evaluation of 2-(1H-pyrazol-1-yl)-1,3,4-thiadiazole derivatives against replicative and infective stages of Trypanosoma cruzi 10.1007/s10863-023-09982-7 2023
Eugenia sulcata (Myrtaceae) Nanoemulsion Enhances the Inhibitory Activity of the Essential Oil on P2X7R and Inflammatory Response In Vivo 10.3390/pharmaceutics14050911 2022
Development of Novel Montmorillonite-Based Sustained Release System for Oral Bromopride Delivery. 10.1016/j.ejps.2022.106222 2022
Synthesis, biological evaluation and molecular modeling studies of novel 1,2,3-triazole-linked menadione-furan derivatives as P2X7 inhibitors 10.1007/s10863-022-09947-2 2022
Evaluation of biological activities of quinone-4-oxoquinoline derivatives against pathogens of clinical importance 10.2174/1568026622666220504124710 2022
Inventive step assessment of top selling monoclonal antibodies in Brazil 10.1080/13543776.2021.1873955 2021
Evaluation of potential MHC-I allele-specific epitopes in Zika virus proteins and the effects of mutations on peptide-MHC-I interaction studied using in silico approaches 10.1016/j.compbiolchem.2021.107459 2021
COVID-19 and SARS-CoV-2: Despite the vaccination, new targets/drugs for treatment and the virus cycle mechanisms still have to be continually investigated 10.17352/ojpg.000010 2021
Possible Pleiotropic Effect Of Sry Gene May Increase Male Susceptibility To Covid-19 10.1093/ajh/hpab093 2021
Synthesis and In Vitro and In Silico Studies of 1H- and 2H-1,2,3-Triazoles as Antichagasic Agents 10.1016/j.bioorg.2021.105250 2021
Physalin pool from Physalis angulata L. leaves and physalin D inhibit P2X7 receptor function in vitro and acute lung injury in vivo 10.1016/j.biopha.2021.112006 2021
Tandem Synthesis of Furanaphthoquinones via Enamines and Evaluation of their Antiparasitic Effects against Trypanosoma cruzi 10.21577/0103-5053.2021 2021
Autismo no Brasil: uma revisão sobre estudos em neurogenética 10.34024/rnc.2021.v29.12440 2021
Down syndrome: the aggravation of COVID-19 may be partially justified by the expression of TMPRSS2 10.1007/s10072-021-05715-z 2021
Synthesis of new N,S-acetal analogs derived from juglone with cytotoxic activity against Trypanossoma cruzi 10.1007/s10863-020-09834-8 2020
Molecular dynamic simulations of full-length human purinergic receptor subtype P2X7 bonded to potent inhibitors 10.1016/j.ejps.2020.105454 2020
P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones 10.1016/j.bioorg.2020.104278 2020
Pharmaceutical Material Engineering: Evaluation of Carvedilol Polymorphs II and III Surface by Packing, Modeling, and Atomic Force Measurements 10.1021/acs.cgd.0c01172 2020
Synthesis, Biological Evaluation, and Molecular Modeling Studies of New Thiadiazole Derivatives as Potent P2X7 Receptor Inhibitors 10.3389/fchem.2019.00261 2019
Arylboronic acids inhibit P2X7 receptor function and the acute inflammatory response 10.1007/s10863-019-09802-x 2019
Molecular modeling as a design tool for sunscreen candidates: a case study of bemotrizinol 10.1007/s00894-019-4237-7 2019
Molecular Modeling for the Investigation of UV Absorbers for Sunscreens: Triazine and Benzotriazole Derivatives 10.1016/j.jphotochem.2017.12.036 2018
1,4-Naphthoquinones potently inhibiting P2X7 receptor activity 10.1016/j.ejmech.2017.10.033 2018
Molecular modeling and dynamic simulations of agglutinin-like family members from Candida albicans : New insights into potential targets for the treatment of candidiasis 10.1080/07391102.2017.1417159 2018
-8-hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into Murine Macrophages 10.1016/j.bmc.2018.11.036 2018
Asymmetric bioreduction of β-ketoesters derivatives by Kluyveromyces marxianus: influence of molecular structure on the conversion and enantiomeric excess 10.1590/0001-3765201720170118 2017
1-Aryl-1 H - and 2-aryl-2 H -1,2,3-triazole derivatives blockade P2X7 receptor in vitro and inflammatory response in vivo 10.1016/j.ejmech.2017.08.034 2017
New carbohydrazide derivatives of 1H-pyrazolo[3,4-b]pyridine and trypanocidal activity 10.1590/0001-3765201620160087 2016
Sodium Montmorillonite/Amine-Containing Drugs Complexes: New Insights on Intercalated Drugs Arrangement into Layered Carrier Material 10.1371/journal.pone.0121110 2015
Protein Kinase CK-1 Inhibitors As New Potential Drugs for Amyotrophic Lateral Sclerosis 10.1021/jm500065f 2014
Enantioselective bioreduction of ethyl 4,4,4-trihalide-3-oxobutanoate by Kluyveromyces marxianus 10.1016/j.tetlet.2013.03.116 2013
Hologram quantitative structure–activity relationship and comparative molecular field analysis studies within a series of tricyclic phthalimide HIV-1 integrase inhibitors 10.2147/dddt.s47057 2013
Trimethoxy-Chalcone derivatives inhibit growth of Leishmania braziliensis: Synthesis, Biological Evaluation, Molecular Modeling and Structure Activity Relationship (SAR) 10.1016/j.bmc.2011.06.023 2011
Synthesis, antitubercular activity, and SAR study of N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides 10.1016/j.bmc.2011.07.035 2011
Antiplatelet activity and structure-activity relationship study of Pyrazolopyridine Derivatives as potential series for treating thrombotic diseases 10.5551/jat.3293 2010
Antimicrobianos: mecanismos de ação e resistência microbiana. Necessidade de novos agentes para tratamento de doenças microbianas 2009
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
Molecular Modeling of Crystal Polymorphism and Potential Co-Crystal Design of Drug Macitentan 2022
Estudo da Formação de Nanopartícula de PLGA Contendo Indometacina por Modelagem e Dinâmica Molecular 2017
Molecular Modeling and Molecular Dynamics Simulations of Molecular Systems Containing Polymers and Indomethacin. 2017
Molecular Modeling and Molecular Dynamics Simulation of Sodium Montmorillonite/Rivastigmine Complex 2014
Ability of Swelling the Organically Modified Montmorillonite in Different Solvents: molecular modeling and molecular dynamics study 2012
Montmorillonite as Pharmaceutical Excipient to Drug-Carrier: Molecular Modeling and Molecular Dynamic of Drug-Clay Nanosystem 2012
Análise de derivados sintéticos da chalcona inibidores do crescimento de Leishmania braziliensis utilizando modelagem molecular (in silico) 2011
Leishmania braziliensis Growth Inhibitors: Molecular Modeling and Structure-Activity Relationship (SAR) of Chalcone Derivatives 2010
Estudo SAR e ADMET IN SILICO de Derivados do Ácido Hidroxâmico com Atividade Antibacteriana 2009
Structure-Activity Relationship (SAR) and Studies In Silico Pharmacokinetic and Toxicological Profile of a Serie of Hydroxamic Acid Derivative with Antibacterial Activity 2009
Publicações:
Minha Rede: